Looking for our Business Solutions? Click here:CloudQuote APIsContact Us
Home
Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Moleculin Biotech Gets EMA Nod For Leukemia Trial: Retail Feels Bullish On ‘Low And Slow’ Setupstocktwits.com
The trial, which will involve sites in the U.S., Europe, and the Middle East, aims to combine Phase 2B and Phase 3 data for efficacy evaluation of the Miracle trial of Annamycin for relapsed or refractory acute myeloid leukemia.
Via Stocktwits · May 13, 2025
These Rotation Trades Could Double Our Profits Tomorrowtalkmarkets.com
After such a big move higher last night, I’m expecting a range to develop over the next couple days. Ranges love to rotate, so these rotation trades are likely where the EASY money will be made!
Via Talk Markets · May 13, 2025
Phillips 66 In Focus After ISS Backs All 4 Elliott Nominees In Proxy Fight, Retail Feels Boardroom Shakeup ‘Looks Inevitable’stocktwits.com
ISS advised shareholders to vote for all four candidates, citing their experience and independence, which Phillips 66 requires.
Via Stocktwits · May 12, 2025
Walmart Q1 Earnings Preview: Analysts Cite 3 Key Reasons Retail Giant Will Power Through Tariff-Driven Uncertaintystocktwits.com
Wall Street expects Walmart’s revenue to rise 2.8% in Q1, while profit is expected to drop.
Via Stocktwits · May 12, 2025
Momentum In “Core” GDPtalkmarkets.com
According to GDPNow of 4/8. However, GDP and final sales are both on a lower trajectory.
Via Talk Markets · May 12, 2025
Financial Markets Report For Monday, May 12talkmarkets.com
In this video, Ira Epstein reviews the activity in the Financial Markets after the day that just ended, Monday, May 12.
Via Talk Markets · May 12, 2025
Rigetti Falls On Q1 Miss But Retail Doubles Down On Stock Amid Faith In Quantum Computing Techstocktwits.com
Revenue fell about 52% year over year to $1.47 million, missing the Finchat-compiled consensus estimate of $2.55 million.
Via Stocktwits · May 12, 2025
Samsung Blindsides Apple With Razor-Thin Galaxy S25 Edge: Here's How Much It Will Costbenzinga.com
Samsung launched the ultra-thin Galaxy S25 Edge early to maintain momentum amid slowing demand and tariff concerns—while preemptively challenging Apple's rumored thin iPhone expected in September.
Via Benzinga · May 12, 2025
Bitcoin, Ethereum, Dogecoin Retreat, Stocks Rally After US-China Tariff De-Escalation: Analyst Sees Opportunity In $2,100-2,250 If ETH Correctsbenzinga.com
Leading cryptocurrencies corrected on Monday even as the U.S. and China slashed tariffs to avert a trade war.
Via Benzinga · May 12, 2025
CytomX Stock Hits 2-Month High After Upbeat Q1 Earnings, Promising Early Data For Cancer Drugstocktwits.com
The company shared Phase 1 trial results for CX-2051, an antibody-drug conjugate for advanced colorectal cancer, with 28% of patients achieving confirmed partial responses.
Via Stocktwits · May 12, 2025
Republicans Target EV Perks With New Bill: Ford, Tesla, Rivian Face Fallout As $200 Billion In Battery Belt Investments Hang In Balancebenzinga.com
House Republicans on Monday introduced legislation to eliminate the electric vehicle tax credit and repeal fuel efficiency rules, potentially disrupting billions in automaker investments amid growing industry concerns about abrupt policy changes.
Via Benzinga · May 12, 2025
Nifty Poised For Rally Toward 25,200–25,400 If This Level Holds, Say SEBI RAsstocktwits.com
Both analysts agree that as long as Nifty holds above 24,750, bulls remain in control — but traders should stay nimble and watch for reversal cues.
Via Stocktwits · May 12, 2025
What’s A New Drug Worth?talkmarkets.com
Trump’s executive order aims to lower U.S. drug costs by capping prices to match those in other countries, addressing the long-standing issue of Americans paying more for brand-name prescriptions. The policy’s legality remains untested in court.
Via Talk Markets · May 12, 2025
The Commodities Feed: Bearish Supply Outlook Vs Improved Sentimentthe-com
Oil prices moved higher following a pause in tariffs by China and the US. However, supply dynamics are likely to continue to generate headwinds.
Via Talk Markets · May 12, 2025
Nasdaq, S&P 500 Futures Dip As Traders Pause For Breather Ahead Of April CPI: Strategist Sees Path To New Highsstocktwits.com
Tariff news flow, first-tier economic data, and a few earnings reports could decide the day's trading direction, although the momentum is decisively in favor of further gains.
Via Stocktwits · May 12, 2025
Dogwifhat Shoots Up 5%: What's Going On?benzinga.com
Dog-themed meme coin Dogwifhat (CRYPTO: WIF) continued its upward march Monday, leaving market heavyweights trailing.
Via Benzinga · May 12, 2025
Craig Shapiro Sees 'Market Kryptonite' In Delayed Fed Liquidity, Dot Plot Reversal Ahead—As China Trade Risks Recedebenzinga.com
On Monday, macro strategist Craig Shapiro shared his views on X, commenting on the narrowing odds of an interest rate cut by the Federal Reserve following the de-escalation of the trade war with China.
Via Benzinga · May 12, 2025
Invivyd Launches New Measles Antibody Discovery Program: Retail Traders Bet On ‘Future Of Medicine’stocktwits.com
Invivyd unveiled a discovery program for a measles-targeted monoclonal antibody, responding to provider demand amid a lack of approved treatments or post-exposure options.
Via Stocktwits · May 12, 2025
Coinbase Stock Soars After-Hours On S&P 500 Inclusion, Retail Eyes New Highsstocktwits.com
The cryptocurrency exchange would join the index before the opening of trading on May 19, S&P Dow Jones Indices said.
Via Stocktwits · May 12, 2025
Can The Nasdaq Rally Be Trustedtalkmarkets.com
In this video, I analyze the factors driving QQQ’s rally, provide my technical analysis, and discuss what this means for investors and traders moving forward.
Via Talk Markets · May 12, 2025
McDonald's Launches Biggest Hiring Drive In Years Despite Sluggish US Restaurant Trafficstocktwits.com
The move comes alongside plans to add 900 stores in the U.S. by 2027.
Via Stocktwits · May 12, 2025
Trump’s ‘Most Favored Nation’ Drug Plan Likely To Face Pushback, JP Morgan Analysts Saystocktwits.com
JPMorgan analysts said President Trump’s "most favored nation" drug pricing order is unlikely to move forward without Congressional support and will likely face legal and industry resistance, limiting its near-term impact on pharma stocks.
Via Stocktwits · May 12, 2025
Alibaba And JD.com Are Literally Paying The Price As China Delivery Wars Heat Upbenzinga.com
Alibaba and JD.com are pouring billions into ultra-fast delivery and steep discounts—like nearly free coffee—to win over cost-conscious Chinese consumers as traditional e-commerce growth slows.
Via Benzinga · May 12, 2025
Trump Tariffs Result In $16B Windfall For April, Rates Still At Nine-Decade Highs Despite UK And China Dealsstocktwits.com
A Yale University report predicts the tariffs will hurt real GDP and economic growth.
Via Stocktwits · May 12, 2025
EUR/USD Takes A Halting Plunge, Tests Below 1.10 As Key Inflation Data Looms Aheadtalkmarkets.com
EUR/USD took a hard step lower on Monday, kicking off the new trading week with a fresh dip below 1.1000 before a late recovery pushed the pair back toward 1.1100.
Via Talk Markets · May 12, 2025